What is the appropriate evaluation and management for a patient with three weeks of persistent nausea, vomiting, and abdominal bloating?

Evaluation and Management of 3-Week Nausea, Vomiting, and Bloating

For a patient with three weeks of persistent nausea, vomiting, and bloating, you must first rule out gastroparesis with a gastric emptying study if nausea and vomiting are prominent, while simultaneously evaluating for alarm symptoms that warrant urgent imaging and endoscopy. 1

Initial Diagnostic Approach

Check for Alarm Symptoms Immediately

Look specifically for:

• Weight loss >10%
• GI bleeding
• Family history of inflammatory bowel disease
• Progressive worsening of symptoms
• Severe or persistent vomiting

If any alarm symptoms are present, proceed directly to:

• Complete blood count, comprehensive metabolic panel
• Abdominal imaging (CT or MRI) to exclude structural abnormalities
• Upper endoscopy to rule out malignancy or obstruction
• Gastric emptying study if nausea/vomiting predominate 1

Medication History is Critical

Stop any potential causative medications immediately:

• Opioids
• GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide) - these can cause gastroparesis that reverses upon discontinuation 2
• Other medications known to delay gastric emptying

This is a common pitfall - GLP-1RA-induced gastroparesis can occur hours to months after initiation, especially after dose escalation, and resolves completely with drug withdrawal 2.

Symptom-Directed Evaluation

If Nausea and Vomiting Predominate

Order a gastric emptying study (scintigraphy) as the primary diagnostic test to differentiate gastroparesis from functional dyspepsia 3, 4. This distinction is essential because:

• Gastroparesis requires prokinetic therapy and dietary modification
• Functional dyspepsia responds to neuromodulators and different management

Before labeling as refractory gastroparesis, ensure:

• Trial of small particle size, reduced fat diet for minimum 4 weeks
• Metoclopramide 10 mg three times daily before meals and at bedtime for at least 4 weeks 3

If Bloating is the Dominant Symptom

Start with a 2-week dietary elimination trial - this is the simplest and most cost-effective first step 1:

• Eliminate lactose, fructose, and artificial sweeteners (sorbitol, sugar alcohols)
• Consider low FODMAP diet
• Resolution of symptoms confirms food intolerance

Only proceed to breath testing (hydrogen/methane) if dietary restriction fails and you suspect carbohydrate malabsorption 1.

Evaluate for Constipation

If constipation is present alongside bloating:

• Apply Rome IV criteria for IBS-C or chronic constipation
• Consider anorectal manometry to diagnose pelvic floor dyssynergia 1

Consider SIBO Only in Specific Contexts

SIBO testing (breath testing or small bowel aspirates) is indicated only if:

• Risk factors present (prior GI surgery, chronic pancreatitis, diabetes, scleroderma)
• Symptoms refractory to dietary modification
• No response to empiric treatment 1

Do not routinely test for SIBO without these risk factors - this is a common overutilization pitfall.

Management Strategy

For Gastroparesis (if confirmed)

1. Dietary modification: Small particle size, low-fat diet for 4+ weeks
2. Metoclopramide: 10 mg TID before meals and at bedtime (FDA-approved, but counsel on tardive dyskinesia risk, though lower than previously estimated) 3
3. If refractory: Consider central antiemetics based on predominant symptom

For Bloating Without Gastroparesis

1. Dietary elimination (2 weeks minimum) 1
2. If food intolerance confirmed: Continue avoidance
3. If refractory: Consider neuromodulators (tricyclic antidepressants, SNRIs) and brain-gut behavioral therapy 1

Symptomatic Treatment

For acute symptom control while pursuing diagnosis:

• 5-HT3 receptor antagonists (ondansetron) are preferred antiemetics - they act on both central and peripheral receptors 5
• IV fluid replacement if dehydration present
• Nasogastric decompression only if severe, intractable vomiting with gastric distension

Common Pitfalls to Avoid

Do not empirically treat for SIBO without risk factors or failed dietary trials - antibiotics are not FDA-approved for this indication and careful patient selection is essential 1.

Do not miss medication-induced gastroparesis - specifically GLP-1 agonists, which are increasingly common and completely reversible 2.

Do not perform gastric emptying studies in patients whose primary symptom is bloating without significant nausea/vomiting - this leads to misdiagnosis and inappropriate treatment 4.

Do not label as functional/refractory disease until you have excluded structural causes with imaging, ruled out medication effects, and completed adequate trials of first-line therapies 3.